SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-013151
Filing Date
2021-04-16
Accepted
2021-04-16 17:20:30
Documents
3
Period of Report
2021-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10023212_8k.htm 8-K 24368
2 EXHIBIT 10.1 brhc10023212_ex10-1.htm EX-10.1 67753
3 EXHIBIT 10.1(A) brhc10023212_ex10-1a.htm EX-10.1(A) 5852
  Complete submission text file 0001140361-21-013151.txt   99526
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 21832407
SIC: 2834 Pharmaceutical Preparations